Voisin Consulting Life Sciences post icon
Press release

VCLS Acquires IWA Consulting ApS to Further Strengthen its Capacities in the Northern Europe

Post thumbnail VCLS Acquires IWA Consulting ApS to Further Strengthen its Capacities in the Northern Europe

Paris, France, July 5th, 2019

We are delighted to announce that we have completed the acquisition of IWA Consulting ApS (IWAC), a Copenhagen-based regulatory consulting company.

Founded in 1997, IWAC offers a complete portfolio of regulatory services to support the development and registration of drugs, biologics and medical devices. The company has 22 dedicated professionals with strong academic background and deep experience across relevant disciplines of regulatory science.

With the addition of IWAC, VCLS is expanding its capabilities in Northern Europe. The combination of IWAC and VCLS will accelerate VCLS goal of becoming the global reference partner in regulatory science to expedite access of HealthTech products to regulated markets.

We are confident that by joining VCLS, IWAC will have the possibility to further grow and strengthen our capability to offer our clients truly global regulatory expertise and to bring them strong EU and FDA regulatory proficiency. We are very pleased to be part of the VCLS family, said the two Managing Partners of IWAC, Lillan Rejkjær and Connie Thestrup.

We are very excited that IWAC decided to join VCLS. Lillan and Connie have built a highly reputable regulatory consulting company in Northern Europe. By reinforcing VCLS regulatory expertise, this acquisition participates to our strategy of building an integrated global offering to efficiently and effectively serve all our clients.  said Dr. Emmanuelle Voisin, Founder & CEO of VCLS.

About Voisin Consulting Life Sciences

Voisin Consulting Life Sciences is a global product development consultancy firm, which guides Biotechnology, Pharmaceutical and Medtech manufacturers throughout product development and commercialization. From discovery to patients, VCLS assists sponsors to design product development strategies through a deep understanding of interactions with both regulators and payers.

VCLS offers integrated solutions to development planning, manufacturing, quality control, nonclinical and clinical development, safety monitoring and clinical operations. With offices in Cambridge (MA, USA), Somerville (NJ, USA), London (UK), Paris and Rennes (France), Lausanne (Switzerland) and Bangalore (India), VCLS serves a broad range of biopharma sponsors and investors.

For more information, visit www.voisinconsulting.com

For media enquiries please contact:

Zhengxi Danard – danard@voisinconsulting.com T: +33 1 41 31 83 00